Pacira BioSciences (PCRX) Short Interest Ratio & Short Volume → Options expert shares his top option strategy for free (From WealthPress) (Ad) Free PCRX Stock Alerts $28.57 -0.55 (-1.89%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Pacira BioSciences Short Interest DataCurrent Short Interest6,040,000 sharesPrevious Short Interest3,600,000 sharesChange Vs. Previous Month+67.78%Dollar Volume Sold Short$181.68 millionShort Interest Ratio9.4 Days to CoverLast Record DateMay 15, 2024Outstanding Shares46,550,000 sharesPercentage of Shares Shorted12.98%Today's Trading Volume452,600 sharesAverage Trading Volume593,980 sharesToday's Volume Vs. Average76% Short Selling Pacira BioSciences ? Sign up to receive the latest short interest report for Pacira BioSciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPCRX Short Interest Over TimePCRX Days to Cover Over TimePCRX Percentage of Float Shorted Over Time Ad Wealthpin ProThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. Pacira BioSciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20246,040,000 shares $181.68 million +67.8%N/A9.4 $30.08 4/30/20243,600,000 shares $94.50 million +4.4%N/A6.7 $26.25 4/15/20243,450,000 shares $91.53 million -7.8%N/A7 $26.53 3/31/20243,740,000 shares $109.28 million -8.1%N/A7.5 $29.22 3/15/20244,070,000 shares $119.70 million -2.4%N/A8.1 $29.41 2/29/20244,170,000 shares $123.93 million +5.8%N/A7.4 $29.72 Get the Latest News and Ratings for PCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/20243,940,000 shares $116.86 million +1.0%N/A7.4 $29.66 1/31/20243,900,000 shares $127.10 million +4.6%N/A6.9 $32.59 1/15/20243,730,000 shares $120.18 million +6.9%N/A7 $32.22 12/31/20233,490,000 shares $117.75 million +7.4%N/A6.5 $33.74 12/15/20233,250,000 shares $101.69 million -0.9%N/A5.8 $31.29 11/30/20233,280,000 shares $89.48 million +2.8%N/A6.7 $27.28 11/15/20233,190,000 shares $91.11 million -11.1%N/A6.4 $28.56 10/31/20233,590,000 shares $101.45 million -8.7%N/A7.5 $28.26 10/15/20233,930,000 shares $114.52 million +12.0%N/A7.7 $29.14 9/30/20233,510,000 shares $107.69 million -0.3%N/A6.5 $30.68 9/15/20233,520,000 shares $118.41 million -1.4%N/A6.8 $33.64 8/31/20233,570,000 shares $126.02 million -4.8%N/A6.3 $35.30 8/15/20233,750,000 shares $139.91 million +9.7%N/A6.6 $37.31 7/31/20233,420,000 shares $124.32 million -3.4%N/A5.9 $36.35 7/15/20233,540,000 shares $132.01 million -2.5%N/A6 $37.29 6/30/20233,630,000 shares $145.45 million -0.6%N/A6.3 $40.07 6/15/20233,650,000 shares $147.17 million +3.7%N/A6.6 $40.32 5/31/20233,520,000 shares $133.87 million +4.5%N/A6.6 $38.03 5/15/20233,370,000 shares $143.12 million +7.7%N/A5.9 $42.47 4/30/20233,130,000 shares $141.82 million +4.0%N/A5.4 $45.31 4/15/20233,010,000 shares $127.77 million No ChangeN/A5.5 $42.45 3/31/20233,010,000 shares $122.84 million -10.4%N/A5.6 $40.81 3/15/20233,360,000 shares $132.25 million -5.9%N/A6.1 $39.36 2/28/20233,570,000 shares $151.97 million No ChangeN/A6.1 $42.57 2/15/20233,570,000 shares $144.91 million -20.7%N/A6.6 $40.59 1/31/20234,500,000 shares $176.72 million -12.8%N/A8.6 $39.27 1/15/20235,160,000 shares $193.09 million +4.2%N/A9.9 $37.42 12/30/20224,950,000 shares $191.12 million +7.1%N/A9.9 $38.61 12/15/20224,620,000 shares $184.38 million -6.3%N/A10.1 $39.91 11/30/20224,930,000 shares $237.87 million -10.5%N/A12.6 $48.25 11/15/20225,510,000 shares $275.50 million +0.7%N/A14.4 $50.00 10/31/20225,470,000 shares $283.13 million +1.7%N/A15.3 $51.76 10/15/20225,380,000 shares $277.61 million +4.3%N/A15.3 $51.60 9/30/20225,160,000 shares $274.46 million +2.2%N/A13.9 $53.19Check out WFC chart (Ad)I’m about to go head-to-head with Wall Street… Exposing one of their BEST kept secrets… A secret that they’ve kept hidden in the dark for YEARS… And according to the backtest, it’s already shown the power to pay out… 28%... 41%... Even 83%... Not in a year… Not in a month… But in just 24 hours…You gotta click here because I’m about to show how to spot what could be the next one. 9/15/20225,050,000 shares $274.06 million +4.3%N/A12.7 $54.27 8/31/20224,840,000 shares $254.00 million +3.9%N/A11.3 $52.48 8/15/20224,660,000 shares $269.02 million +1.8%N/A10.7 $57.73 7/31/20224,580,000 shares $259.04 million -0.2%N/A9.7 $56.56 7/15/20224,590,000 shares $252.45 million +5.8%N/A9.2 $55.00 6/30/20224,340,000 shares $253.02 million -12.9%N/A8.3 $58.30 6/15/20224,980,000 shares $271.66 million -3.1%12.5%9.4 $54.55 5/31/20225,140,000 shares $325.11 million +0.2%N/A9.9 $63.25 5/15/20225,130,000 shares $315.75 million -3.9%N/A9.2 $61.55 4/30/20225,340,000 shares $398.20 million +3.5%N/A9.5 $74.57 4/15/20225,160,000 shares $385.35 million -8.0%11.8%9.3 $74.68 3/31/20225,610,000 shares $428.16 million -3.3%12.9%10.3 $76.32 3/15/20225,800,000 shares $409.42 million -7.9%13.3%11.6 $70.59 2/28/20226,300,000 shares $420.15 million -4.8%14.4%12 $66.69 2/15/20226,620,000 shares $428.58 million -1.1%15.3%13.3 $64.74 1/31/20226,690,000 shares $419.93 million +5.2%15.4%13.5 $62.77 1/15/20226,360,000 shares $407.55 million -6.5%14.7%13.2 $64.08 12/31/20216,800,000 shares $409.16 million -0.2%15.7%14.5 $60.17 12/15/20216,810,000 shares $392.05 million -0.7%15.7%13.1 $57.57 11/30/20216,860,000 shares $360.97 million +4.9%15.8%13.8 $52.62 11/15/20216,540,000 shares $366.17 million -3.8%15.1%14.3 $55.99 10/29/20216,800,000 shares $355.50 million +3.8%15.7%15 $52.28 10/15/20216,550,000 shares $348.46 million -5.4%15.1%14.8 $53.20 9/30/20216,920,000 shares $387.52 million -3.4%16.0%16.4 $56.00 9/15/20217,160,000 shares $395.09 million +5.6%16.5%20.6 $55.18 8/31/20216,780,000 shares $401.99 million +1.8%15.6%17.6 $59.29 8/13/20216,660,000 shares $388.41 million -1.3%15.4%17 $58.32 7/30/20216,750,000 shares $397.91 million -2.7%15.6%16.1 $58.95 7/15/20216,940,000 shares $389.13 million +3.1%16.2%16.4 $56.07 6/30/20216,730,000 shares $408.38 million -4.3%15.7%14.9 $60.68 6/15/20217,030,000 shares $419.55 million -0.9%16.4%15.3 $59.68 5/28/20217,090,000 shares $430.15 million +1.9%16.5%16.2 $60.67 5/14/20216,960,000 shares $427.76 million -2.8%N/A16.3 $61.46 4/30/20217,160,000 shares $459.67 million -0.3%N/A16.6 $64.20 4/15/20217,180,000 shares $498.51 million -3.5%N/A15.9 $69.43 3/31/20217,440,000 shares $526.90 million +5.5%N/A15.4 $70.82 3/15/20217,050,000 shares $517.96 million +4.4%N/A14.6 $73.47 2/26/20216,750,000 shares $502.54 million +13.8%N/A13.8 $74.45 2/12/20215,930,000 shares $466.69 million -4.8%N/A12 $78.70 1/29/20216,230,000 shares $416.97 million -5.2%N/A12.5 $66.93 1/15/20216,570,000 shares $506.94 million -6.8%N/A13.5 $77.16 12/31/20207,050,000 shares $413.91 million +13.5%N/A15.4 $58.71 12/15/20206,210,000 shares $365.77 million +8.8%N/A14.5 $58.90 11/30/20205,710,000 shares $364.30 million -3.9%N/A12.9 $63.80 11/15/20205,940,000 shares $378.02 million -2.6%N/A13.5 $63.64 10/30/20206,100,000 shares $324.03 million +5.5%N/A13.6 $53.12 10/15/20205,780,000 shares $335.47 million +1.9%N/A11.2 $58.04 9/30/20205,670,000 shares $340.88 million -8.7%N/A10.4 $60.12 9/15/20206,210,000 shares $367.69 million -3.0%N/A8.6 $59.21 8/31/20206,400,000 shares $400.13 million -11.4%N/A8.9 $62.52Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. 8/14/20207,220,000 shares $442.08 million -11.2%N/A9.6 $61.23 7/31/20208,130,000 shares $427.72 million +1.0%N/A10.7 $52.61 7/15/20208,050,000 shares $445.41 million +23.9%N/A11.3 $55.33 6/30/20206,500,000 shares $341.06 million +18.2%N/A9 $52.47 6/15/20205,500,000 shares $238.76 million +3.2%N/A9 $43.41 5/29/20205,330,000 shares $234.25 million +1.1%N/A7.3 $43.95 5/15/20205,270,000 shares $212.28 million +1.9%N/A7.1 $40.28 4/30/20205,170,000 shares $213.47 million +11.9%N/A7 $41.29 4/15/20204,620,000 shares $164.01 million +16.7%N/A6.6 $35.50 3/31/20203,960,000 shares $157.57 million -8.6%N/A5.7 $39.79 3/13/20204,332,500 shares $154.63 million -2.4%N/A4.9 $35.69 2/28/20204,440,000 shares $126.10 million +0.5%N/A8.4 $28.40 2/14/20204,420,000 shares $163.10 million -0.7%N/A8.7 $36.90 1/31/20204,450,000 shares $200.87 million +7.0%11.0%9.2 $45.14 1/15/20204,160,000 shares $207.92 million +10.9%10.3%8.7 $49.98 12/31/20193,750,000 shares $164.29 million +0.8%9.3%7.8 $43.81 PCRX Short Interest - Frequently Asked Questions What is Pacira BioSciences' current short interest? Short interest is the volume of Pacira BioSciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 6,040,000 shares of PCRX short. Learn More on Pacira BioSciences' current short interest. What is a good short interest ratio for Pacira BioSciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PCRX shares currently have a short interest ratio of 9.0. Learn More on Pacira BioSciences's short interest ratio. Which institutional investors are shorting Pacira BioSciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pacira BioSciences: Walleye Trading LLC, HAP Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Pacira BioSciences' short interest increasing or decreasing? Pacira BioSciences saw a increase in short interest in May. As of May 15th, there was short interest totaling 6,040,000 shares, an increase of 67.8% from the previous total of 3,600,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pacira BioSciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Pacira BioSciences: OPKO Health, Inc. (26.01%), ALX Oncology Holdings Inc. (11.56%), Atea Pharmaceuticals, Inc. (2.53%), ADC Therapeutics SA (1.36%), Seres Therapeutics, Inc. (15.01%), Perrigo Company plc (3.08%), Corcept Therapeutics Incorporated (22.07%), Supernus Pharmaceuticals, Inc. (9.33%), Nektar Therapeutics (1.49%), Omeros Co. (24.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Pacira BioSciences stock? Short selling PCRX is an investing strategy that aims to generate trading profit from Pacira BioSciences as its price is falling. PCRX shares are trading down $0.55 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pacira BioSciences? A short squeeze for Pacira BioSciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PCRX, which in turn drives the price of the stock up even further. How often is Pacira BioSciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PCRX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: OPKO Health Short Interest Data ALX Oncology Short Interest Data Atea Pharmaceuticals Short Interest Data ADC Therapeutics Short Interest Data Seres Therapeutics Short Interest Data Perrigo Short Interest Data Corcept Therapeutics Short Interest Data Supernus Pharmaceuticals Short Interest Data Nektar Therapeutics Short Interest Data Omeros Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PCRX) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacira BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.